The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
The next generation of evidence-based medicine
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High-performance medicine: the convergence of human and artificial intelligence
Topol, E. J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0300-7 · Cited by 10,450
Innovation in the pharmaceutical industry: New estimates of R&D costs
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.01.012 · Cited by 3,359 · cited 1×
“3, 4).”
Rajpurkar, P., Chen, E., Banerjee, O., & Topol, E. J. (2022) · Nature Medicine · doi:10.1038/s41591-021-01614-0 · Cited by 3,212
Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation
Perez, M. V., Mahaffey, K. W., Hedlin, H., Rumsfeld, J. S., Garcia, A., Ferris, T., Balasubramanian, V., Russo, A. M., Rajmane, A., Cheung, L., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1901183 · Cited by 1,917
Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database
Nguengang Wakap, S., Lambert, D. M., Olry, A., Rodwell, C., Gueydan, C., Lanneau, V., Murphy, D., Le Cam, Y., & Rath, A. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-019-0508-0 · Cited by 1,752
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
Wouters, O. J., McKee, M., & Luyten, J. (2020) · JAMA · doi:10.1001/jama.2020.1166 · Cited by 1,531
Liu, X., Cruz Rivera, S., Moher, D., Calvert, M. J., Denniston, A. K., The SPIRIT-AI and CONSORT-AI Working Group, SPIRIT-AI and CONSORT-AI Steering Group, Chan, A.-W., Darzi, A., Holmes, C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1034-x · Cited by 1,421
Acosta, J. N., Falcone, G. J., Rajpurkar, P., & Topol, E. J. (2022) · Nature Medicine · doi:10.1038/s41591-022-01981-2 · Cited by 1,365
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
Woodcock, J., & LaVange, L. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1510062 · Cited by 1,020
Cruz Rivera, S., Liu, X., Chan, A.-W., Denniston, A. K., Calvert, M. J., The SPIRIT-AI and CONSORT-AI Working Group, SPIRIT-AI and CONSORT-AI Steering Group, Darzi, A., Holmes, C., Yau, C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1037-7 · Cited by 933
Research works printed but not linked: 13
- Flaherty, K. T. et al. Rethinking cancer clinical trial conduct induced by COVID-19: an academic center, industry, government, and regulatory agency perspective. Cancer Discov. 11, 1881–1885 (2021). · doi:10.1158/2159-8290.cd-21-0850
- Menta, A. K., Subbiah, I. M. & Subbiah, V. Bringing wearable devices into oncology practice: fitting smart technology in the clinic. Discov. Med. 26, 261–270 (2018).
- Normand, S.-L. T. The RECOVERY platform. N. Engl. J. Med. 384, 757–758 (2020). · DOI
- Dickson, D. et al. Snapshot: trial types in precision medicine. Cell 181, 208 (2020). · doi:10.1016/j.cell.2020.02.032
- Wickström, K. & Moseley, J. Biomarkers and surrogate endpoints in drug development: a european regulatory view. Invest. Ophthalmol. Vis. Sci. 58, BIO27–BIO33 (2017). · doi:10.1167/iovs.17-21778
- FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource https://www.ncbi.nlm.nih.gov/books/NBK326791/ (2016).
- Desai, A. & Subbiah, V. COVID-19 pandemic and cancer clinical trial pandemonium: finding the silver lining. J. Immunother. Precis. Oncol. 4, 64–66 (2020). · doi:10.36401/jipo-20-x7
- Anderson, A. S. A lightspeed approach to pandemic drug development. Nat. Med. 28, 1538 (2022). · doi:10.1038/s41591-022-01945-6
- Moyers, J. T. & Subbiah, V. Think globally, act locally: globalizing precision oncology. Cancer Discov. 12, 886–888 (2022). · doi:10.1158/2159-8290.cd-22-0024
- Ramagopalan, S. V. et al. Transportability of overall survival estimates from US to Canadian patients with advanced non–small cell lung cancer with implications for regulatory and health technology assessment. JAMA Netw. Open 5, e2239874 (2022). · doi:10.1001/jamanetworkopen.2022.39874
- McCune, S. & Portman, R. J. Innovation and opportunities in pediatric therapeutic development. Ther. Innov. Regul. Sci. 53, 564–566 (2019). · doi:10.1177/2168479019869754
- Subbiah, V. Fast-tracking novel drugs in pediatric oncology. Cell Cycle 14, 1127–1128 (2015). · doi:10.1080/15384101.2015.1018049
- Morgan, G. et al. The (r)evolution of social media in oncology: engage, enlighten, and encourage. Cancer Discov. 12, 1620–1624 (2022). · doi:10.1158/2159-8290.cd-22-0346
Cited by
Gerstberger, S., Jiang, Q., & Ganesh, K. (2023) · Cell · doi:10.1016/j.cell.2023.03.003 · Cited by 913
Assessing the Risk of Bias in Randomized Clinical Trials With Large Language Models
Lai, H., Ge, L., Sun, M., Pan, B., Huang, J., Hou, L., Yang, Q., Liu, J., Liu, J., Ye, Z., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.12687 · Cited by 103
Derraz, B., Breda, G., Kaempf, C., Baenke, F., Cotte, F., Reiche, K., Köhl, U., Kather, J. N., Eskenazy, D., & Gilbert, S. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00517-w · Cited by 94
Digital twin systems for musculoskeletal applications: A current concepts review
Diniz, P., Grimm, B., Garcia, F., Fayad, J., Ley, C., Mouton, C., Oeding, J. F., Hirschmann, M. T., Samuelsson, K., & Seil, R. (2025) · Knee Surgery, Sports Traumatology, Arthroscopy · doi:10.1002/ksa.12627 · Cited by 60
Muse, E. D., & Topol, E. J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.02.002 · Cited by 50
Metadata
- Authors
- Subbiah, V.
- Venue
- Nature Medicine
- Published
- 2023-01
- Volume
- 29
- Issue
- 1
- Pages
- 49-58
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W4316507348
- Cited by
- 544
- References
- 67
- FWCI
- 107.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Funders
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA242845, R01CA273168, P30 CA016672)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The next generation of evidence-based medicine. https://app.cochat.ai/papers/10.1038/s41591-022-02160-z
- The paper
- Subbiah, V. (2023). The next generation of evidence-based medicine. Nature Medicine. https://doi.org/10.1038/s41591-022-02160-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.